Abstract
Mycobacterium bovis is best identified by screening those isolates of the Mycobacterium tuberculosis complex that have any pyrazinamide (PZA) resistance, using a confirmatory test such as spoligotyping, biochemical testing, or genomic deletion analysis. The sensitivity for detection of M. bovis is lowered to 82% when only PZA-monoresistant isolates are screened.
Original language | English (US) |
---|---|
Pages (from-to) | 3530-3532 |
Number of pages | 3 |
Journal | Journal of Clinical Microbiology |
Volume | 43 |
Issue number | 7 |
DOIs | |
State | Published - Jul 2005 |
Externally published | Yes |
ASJC Scopus subject areas
- Microbiology (medical)
- Microbiology